Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SAP vs MRNA✓SelectedUSD · MRNASAP vs MRNA performance historyLatest closeAs of-2.12%11/20
Stock and ETF performance explorer

SAP vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+34.9%
MRNA return
+153.9%
Excess return
-119.0%
Maximum drawdown
-52.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.1%-2.2%+0.1%-2.1%
7D-15.3%-12.7%-2.6%-15.1%
30D-14.5%-20.7%+6.1%-14.2%
3M-8.4%+46.3%-54.6%-9.3%
6M+10.6%+305.2%-294.7%+4.1%
YTD-16.7%+561.2%-577.9%-24.8%
1Y-13.5%+772.1%-785.6%-23.7%
3Y+34.9%+147.0%-112.1%+30.1%
All+34.9%+153.9%-119.0%+30.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling